CMAB Biopharma - Ownership and Business Overview

Life ScienceCompany

CMAB Biopharma Ownership

Who owns CMAB Biopharma?

CMAB Biopharma is owned by WuXi Biologics. It was acquired on May 7, 2021.

CMAB Biopharma Business Overview

Where is CMAB Biopharma headquartered?

CMAB Biopharma is headquartered in Suzhou, China.

What sector is CMAB Biopharma in?

CMAB Biopharma is a life science company.

When was CMAB Biopharma founded?

CMAB Biopharma was founded in 2017.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 389 acquisitions of life science companies in 2021, including 45 acquisitions by private equity firms, and 344 by strategics.

CMAB Biopharma

CMAB BioPharma (Suzhou), Inc.

Building C37, No. 188 Dong Ping Road,
Suzhou, 215123
China,
(+86) 0512 6799 5188
www.cmabbio.com

CMAB Biopharma is a full-service contract development and manufacturing organization (CDMO) dedicated to providing process development and manufacturing services for biologic products. The company provides bespoke development manufacturing services of antibodies and biologics for clients in China and across the globe. Its adaptable, service-oriented business enables clients to take their innovative concepts for tomorrow’s medicines from DNA to clinical products today. CMAB Biopharma was formed in 2017 and is based in Suzhou, China.


Company Summary

SECTOR

Life Science

Established

2017

 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for CMAB Biopharma

Life Science Companies , China Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for China Companies

Largest China Companies , Acquisitive China Companies , Recently Acquired China Companies , Recently Sold China Companies , Private China Companies , Public China Companies , Acquired China Companies , PE Backed China Companies
Mergr

Product

Company

Legal